MUSL — Promino Nutritional Sciences Cashflow Statement
0.000.00%
Last trade - 00:00- CA$8.80m
- CA$10.83m
- CA$2.15m
Annual cashflow statement for Promino Nutritional Sciences, fiscal year end - December 31st, CAD millions except per share, conversion factor applied.
2021 December 31st | 2022 December 31st | 2023 December 31st | C2024 December 31st | 2025 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | ARS | ARS | ARS | ARS | ARS |
| Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | -8.78 | -10.3 | -5.81 | -7.07 | -2.99 |
| Depreciation | |||||
| Non-Cash Items | 1.57 | 1.63 | 1.41 | 2.5 | -0.053 |
| Unusual Items | |||||
| Other Non-Cash Items | |||||
| Changes in Working Capital | -2.81 | 4.19 | 2.58 | -1.06 | 1.77 |
| Change in Accounts Receivable | |||||
| Change in Inventories | |||||
| Change in Prepaid Expenses | |||||
| Change in Payable / Accrued Expenses | |||||
| Other Operating Cash Flow | |||||
| Cash from Operating Activities | -9.94 | -4.5 | -1.79 | -5.63 | -1.28 |
| Capital Expenditures | -0.037 | -0.023 | — | — | — |
| Purchase of Fixed Assets | |||||
| Other Investing Cash Flow Items | 0 | 0.003 | 0.001 | 2.34 | 0.241 |
| Sale of Business | |||||
| Sale of Fixed Assets | |||||
| Sale/Maturity of Investment | |||||
| Purchase of Investments | |||||
| Other Investing Cash Flow | |||||
| Cash from Investing Activities | -0.037 | -0.02 | 0.001 | 2.34 | 0.241 |
| Financing Cash Flow Items | -1.17 | -0.415 | 0 | -0.226 | -0.028 |
| Other Financing Cash Flow | |||||
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | 10.5 | 4.29 | 1.72 | 3.42 | 0.915 |
| Foreign Exchange Effects | |||||
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | 0.405 | -0.489 | -0.003 | 0.146 | -0.122 |